ArticleBiomolecules & biomedicine2024

Which factors help to determine the long-term response to first-line tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma: A Turkish multi-centre study.

Nargiz Majidova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.